Aveanna Healthcare Raises FY2025 Guidance and Provides Initial FY2026 Outlook
Summary
Aveanna Healthcare Holdings, Inc. announced updated full-year 2025 guidance, raising revenue and Adjusted EBITDA expectations, and provided initial full-year 2026 guidance.
Key Events
-
Updated FY2025 Revenue Guidance
The company raised its full-year 2025 revenue guidance to a range of $2.425 billion to $2.445 billion, up from its previous expectation of greater than $2.375 billion.
-
Updated FY2025 Adjusted EBITDA Guidance
Aveanna increased its full-year 2025 Adjusted EBITDA guidance to a range of $318 million to $322 million, an increase from its prior guidance of greater than $300 million.
-
Initial FY2026 Guidance Provided
For fiscal year 2026, the company expects revenue between $2.54 billion and $2.56 billion, and Adjusted EBITDA between $318 million and $322 million.
Analysis
Aveanna Healthcare Holdings, Inc. has updated its financial outlook, raising its full-year 2025 revenue and Adjusted EBITDA guidance. This positive revision suggests stronger performance than previously anticipated for the current fiscal year. Additionally, the company provided its initial full-year 2026 guidance, offering investors a forward-looking perspective on its expected financial trajectory. The increased guidance for 2025 indicates operational strength and could lead to positive market sentiment.
At the time of this filing, AVAH was trading at $8.55 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.8B. The 52-week trading range was $3.67 to $10.32. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.